Allegro Diagnostics
Development of genomic tests to support the diagnosis and management of lung cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€20—29m (Dealroom.co estimates Jul 2011.)
Maynard Iowa (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | $4.0m | Series A | |
* | $2.8m | Grant | |
$5.4m | Series A | ||
N/A | Acquisition | ||
Total Funding | €11.1m |
Related Content
Recent News about Allegro Diagnostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.